← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap — 3,142 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Most overvalued Most shorted Buyers' strike Largest
AACB
AACB
Valuation N/A
Price$10.59
Model IV—
P/IV—
Limited data — see page
AACBR
AACBR
Valuation N/A
Price$0.01
Model IV—
P/IV—
Limited data — see page
AACBU
AACBU
Valuation N/A
Price$10.70
Model IV—
P/IV—
Limited data — see page
AACG
ATA Creativity Global
Deeply overvalued
Consumer Defensive
Price$0.69
Model IV$0.25
P/IV3.25
Premium +178% Return to IV: -64.1%
Market implies +12.1%/yr vs model +4.8% · above model
AACI
Armada Acquisition Corp. III
Valuation N/A
Financial Services
Price$10.07
Model IV—
P/IV—
Limited data — see page
AACIU
Armada Acquisition Corp. III
Valuation N/A
Financial Services
Price$10.32
Model IV—
P/IV—
Limited data — see page
AACIW
Armada Acquisition Corp. III
Valuation N/A
Financial Services
Price$0.21
Model IV—
P/IV—
Limited data — see page
AACO
Abony Acquisition Corp. I
Valuation N/A
Financial Services
Price$9.98
Model IV—
P/IV—
Limited data — see page
AACOU
Abony Acquisition Corp. I
Valuation N/A
Financial Services
Price$10.10
Model IV—
P/IV—
Limited data — see page
AACOW
Abony Acquisition Corp. I
Valuation N/A
Financial Services
Price$0.37
Model IV—
P/IV—
Limited data — see page
AACP
Apogee Acquisition Corp
Valuation N/A
Financial Services
Price$10.07
Model IV—
P/IV—
Limited data — see page
AACPU
Apogee Acquisition Corp
Valuation N/A
Financial Services
Price$10.28
Model IV—
P/IV—
Limited data — see page
AAME
ATLANTIC AMERICAN CORP
Deeply undervalued
Financial Services
Price$1.18
Model IV$1.91
P/IV0.71
Discount 38% Return to IV: +62.1%
AARD
Aardvark Therapeutics, Inc.
Valuation N/A
Healthcare
Price$4.76
Model IV—
P/IV—
Limited data — see page
ABLV
Able View Global Inc.
Deeply overvalued
Consumer Cyclical
Price$2.39
Model IV$0.24
P/IV5.46
Premium +904% Return to IV: -90.0%
Market implies +35.4%/yr vs model +4.8% · above model
ABLVW
Able View Global Inc.
Valuation N/A
Consumer Cyclical
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr
ABOS
Acumen Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$2.14
Model IV—
P/IV—
Limited data — see page
ABTS
Abits Group Inc
Deeply undervalued
Financial Services
Price$1.20
Model IV$6.20
P/IV0.20
Discount 81% Return to IV: +416.3%
Market implies -30.5%/yr vs model +50.0% · below model
ABVC
ABVC BIOPHARMA, INC.
Valuation N/A
Healthcare
Price$1.00
Model IV—
P/IV—
Market implies +65.6%/yr
ABVE
ABVE
Valuation N/A
Price$0.11
Model IV—
P/IV—
Limited data — see page
ABVEW
ABVEW
Valuation N/A
Price$0.02
Model IV—
P/IV—
Limited data — see page
ACAA
Averin Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$10.02
Model IV—
P/IV—
Limited data — see page
ACAAU
Averin Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$10.10
Model IV—
P/IV—
Limited data — see page
ACAAW
Averin Capital Acquisition Corp.
Valuation N/A
Financial Services
Price$0.70
Model IV—
P/IV—
Limited data — see page
ACB
AURORA CANNABIS INC
Fairly valued
Healthcare
Price$4.49
Model IV$4.74
P/IV0.90
Discount 5% Return to IV: +5.6%
Market implies -3.3%/yr vs model +5.4% · below model
ACCL
Acco Group Holdings Ltd
Deeply overvalued
Industrials
Price$2.68
Model IV$0.88
P/IV2.85
Premium +205% Return to IV: -67.3%
Market implies +18.8%/yr vs model +8.7% · above model
ACCS
ACCESS Newswire Inc.
Deeply overvalued
Industrials
Price$4.59
Model IV$2.48
P/IV1.93
Premium +85% Return to IV: -45.9%
Market implies +7.3%/yr vs model +2.0% · above model
ACET
Adicet Bio, Inc.
Valuation N/A
Healthcare
Price$5.61
Model IV—
P/IV—
Limited data — see page
ACFN
ACORN ENERGY, INC.
Deeply overvalued
Industrials
Price$18.69
Model IV$10.43
P/IV2.01
Premium +79% Return to IV: -44.2%
Market implies +12.8%/yr vs model +8.4% · above model
ACGC
ACP Holdings Acquisition Corp.
Valuation N/A
Financial Services
Price$10.06
Model IV—
P/IV—
Limited data — see page
ACGCU
ACP Holdings Acquisition Corp.
Valuation N/A
Financial Services
Price$10.24
Model IV—
P/IV—
Limited data — see page
ACH
ACCENDRA HEALTH INC/VA/
Valuation N/A
Industrials
Price$0.43
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
ACIU
AC Immune SA
Valuation N/A
Healthcare
Price$2.50
Model IV—
P/IV—
Market implies +54.2%/yr
ACNT
ASCENT INDUSTRIES CO.
Deeply overvalued
Basic Materials
Price$13.55
Model IV$10.33
P/IV1.42
Premium +31% Return to IV: -23.8%
Market implies +5.9%/yr vs model +5.0% · in line
ACOG
Alpha Cognition Inc.
Valuation N/A
Healthcare
Price$9.04
Model IV—
P/IV—
Market implies +25.9%/yr
ACON
Aclarion, Inc.
Valuation N/A
Healthcare
Price$2.34
Model IV—
P/IV—
Market implies +31.4%/yr
ACONW
Aclarion, Inc.
Deeply undervalued
Healthcare
Price$0.02
Model IV$0.06
P/IV0.49
Discount 65% Return to IV: +184.4%
Market implies -25.0%/yr vs model +5.9% · below model
ACR
ACRES Commercial Realty Corp.
Valuation N/A
Financial Services
Price$10.45
Model IV—
P/IV—
Limited data — see page
ACRE
Ares Commercial Real Estate Corp
Undervalued
Financial Services
Price$3.55
Model IV$4.55
P/IV0.92
Discount 22% Return to IV: +28.1%
ACRV
Acrivon Therapeutics, Inc.
Valuation N/A
Healthcare
Price$1.91
Model IV—
P/IV—
Limited data — see page
ACTU
ACTUATE THERAPEUTICS, INC.
Valuation N/A
Healthcare
Price$0.61
Model IV—
P/IV—
Limited data — see page
ACU
ACME UNITED CORP
Deeply overvalued
Industrials
Price$62.15
Model IV$15.23
P/IV4.12
Premium +308% Return to IV: -75.5%
Market implies +21.6%/yr vs model +4.8% · above model
ACV
Virtus Diversified Income & Convertible Fund
Valuation N/A
Unknown
Price$24.87
Model IV—
P/IV—
Limited data — see page
ACXP
Acurx Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$1.27
Model IV—
P/IV—
Limited data — see page
ADAC
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$10.06
Model IV—
P/IV—
Limited data — see page
ADACU
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$10.52
Model IV—
P/IV—
Limited data — see page
ADACW
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$0.37
Model IV—
P/IV—
Limited data — see page
ADAG
Adagene Inc.
Valuation N/A
Healthcare
Price$2.76
Model IV—
P/IV—
Market implies +43.5%/yr
ADCT
ADC Therapeutics SA
Deeply overvalued
Healthcare
Price$1.73
Model IV$0.99
P/IV1.29
Premium +75% Return to IV: -43.0%
Market implies +6.1%/yr vs model +24.5% · below model
ADGM
Adagio Medical Holdings, Inc.
Valuation N/A
Healthcare
Price$0.13
Model IV—
P/IV—
Market implies +20.6%/yr
ADIL
ADIAL PHARMACEUTICALS, INC.
Valuation N/A
Healthcare
Price$3.90
Model IV—
P/IV—
Limited data — see page
ADSEW
Ads-Tec Energy Public Ltd Co
Valuation N/A
Technology
Price$0.24
Model IV—
P/IV—
Market implies -50.0%/yr
ADTX
Aditxt, Inc.
Valuation N/A
Healthcare
Price$0.00
Model IV—
P/IV—
Market implies +60.0%/yr
ADVB
Advanced Biomed Inc.
Valuation N/A
Healthcare
Price$5.31
Model IV—
P/IV—
Limited data — see page
ADX
ADAMS DIVERSIFIED EQUITY FUND, INC.
Valuation N/A
Unknown
Price$26.17
Model IV—
P/IV—
Limited data — see page
AEAQ
Activate Energy Acquisition Corp.
Valuation N/A
Financial Services
Price$10.08
Model IV—
P/IV—
Limited data — see page
AEAQU
Activate Energy Acquisition Corp.
Valuation N/A
Financial Services
Price$10.29
Model IV—
P/IV—
Limited data — see page
AEAQW
Activate Energy Acquisition Corp.
Valuation N/A
Financial Services
Price$0.31
Model IV—
P/IV—
Limited data — see page
AEC
ANFIELD ENERGY INC.
Valuation N/A
Basic Materials
Price$3.29
Model IV—
P/IV—
Limited data — see page
AEHL
Antelope Enterprise Holdings Ltd
Fairly valued
Communication Services
Price$9.87
Model IV$10.73
P/IV0.72
Discount 8% Return to IV: +8.7%
Market implies -0.3%/yr vs model +15.0% · below model